Procode has hired Blair Baker as Chief Operating Officer directly from Optum, where he served as CIO of RCM Innovation. On the surface, this is an executive hire. Strategically, it is much more interesting: Procode is bringing in an operator whose mandate is to consolidate acquired billing companies into one operating model and push Procode's AI into every coding, billing, collections, and client-service workflow.
That is the hard part of the AI-enabled RCM roll-up thesis.
Buying specialty billing companies is relatively straightforward. Building useful AI is increasingly achievable. Turning multiple acquired service businesses into one scaled platform — without losing specialty expertise, client relationships, or financial performance — is where most roll-ups either create value or destroy it.
Procode says it already serves more than 350 plastic-surgery and dermatology providers through The Auctus Group, with $14 million in total venture funding behind its AI-enabled acquisition strategy.
Procode's technology story was already established.
The company has built surgical coding AI, launched Procollect as an operating system for billing teams, acquired The Auctus Group, raised $14 million in total venture capital, and published peer-reviewed coding results that helped establish credibility around its specialty-AI approach.
Now the bottleneck shifts from product proof to operating execution.
Baker will lead two explicit priorities:
That is not a typical COO mandate.
It is a post-acquisition integration mandate combined with an AI transformation mandate.
The AI-enabled RCM roll-up model only works if the buyer can convert acquired labor-intensive businesses into a common technology-enabled operating system. Procode is hiring an executive whose job is explicitly to make that conversion happen.
Baker brings more than 35 years of revenue-cycle experience, beginning in hospital patient access and patient accounting before moving into RCM technology, product, operations, and delivery.
Most recently, he was CIO of RCM Innovation at Optum, where Procode says he led a product organization focused on AI- and automation-first revenue-cycle capabilities for hospitals and health systems.
Before Optum, Baker was COO and Chief Product Officer of AccuReg from 2020 through its acquisition by Optum in 2023. His responsibilities spanned implementations, customer support, technology-enabled services, product, engineering, AI, UX, and IT.
Earlier roles included MEDHOST, where he managed a portfolio producing $220 million in annual recurring revenue, and Emdeon, where he led end-to-end RCM product across a $52 million P&L.
That background matters because Procode does not just need someone who understands AI.
It needs someone who understands what happens when software, service delivery, acquired teams, implementation, and enterprise operating discipline all collide.
Procode CEO Jeff Cripe describes the strategy directly: acquire strong surgical billing companies and make them better with AI.
That sounds simple. Economically, it is powerful if it works.
A traditional RCM acquisition buys revenue, customers, employees, contracts, and specialty expertise.
An AI-enabled acquisition strategy adds another layer:
Can the buyer increase the productivity and margin of the acquired company after closing?
If coding becomes more automated, collections workflows become more intelligent, reporting becomes standardized, and operating systems are shared across the portfolio, the acquirer is not merely consolidating EBITDA.
It is attempting to manufacture more EBITDA from the same revenue base.
That is a fundamentally different roll-up thesis.
Private-practice surgical billing is fragmented.
The businesses often have strong client relationships and deep specialty expertise but limited budgets for engineering, AI, data infrastructure, or workflow redesign.
That creates an asymmetry.
The local or specialty billing company may know the surgeon, payer rules, coding nuance, and collections process better than a large horizontal vendor.
But it may not be able to build a proprietary AI stack.
An acquirer like Procode can potentially preserve the specialty knowledge while spreading one technology platform across multiple acquired businesses.
This is exactly the kind of market where AI can become a consolidation advantage rather than simply a software product.
The acquired billing company brings customers, workflow knowledge, and trust. The platform brings AI, capital, data, and operating leverage. The value is created when those two sides actually integrate.
The hire also changes how Procode should be categorized.
A pure software company sells tools to billing organizations.
A traditional RCM company performs the work.
Procode is increasingly trying to do both.
It owns billing operations through acquired businesses. It builds proprietary AI. It operates coding infrastructure. It is developing Procollect as the workflow layer for billing teams. And now it is hiring enterprise operating leadership to standardize the portfolio.
The end state looks less like SaaS and more like an AI-enabled RCM operating company.
That model is becoming increasingly common across healthcare administration.
Software companies want workflow ownership.
Service companies want software leverage.
Private equity wants consolidation.
AI makes the boundaries between all three less clear.
Baker is moving from one of healthcare's largest administrative and RCM platforms into a much smaller company focused on private-practice surgery.
That is not important because Procode is trying to become Optum.
It is important because the operating lessons from enterprise RCM are moving downstream.
Large health systems have already spent years building centralized revenue-cycle operations, automation programs, standardized workflows, data platforms, and enterprise AI capabilities.
Smaller specialty practices rarely have that infrastructure.
Procode's thesis is effectively that the same operating sophistication can be delivered to fragmented private practices through an acquired-services platform.
Baker's role is to translate enterprise-scale operating discipline into that environment.
Procode's earlier story was about whether its AI could actually code complex surgery.
The next test is different.
Can the company integrate acquired teams without disrupting clients?
Can it standardize workflows while preserving specialty-specific expertise?
Can Procollect become the common operating system across acquisitions?
Can AI-driven productivity gains show up in collections, labor efficiency, EBITDA, and client retention?
And can those gains repeat across specialties beyond plastic surgery and dermatology?
Those are operating questions, not model-benchmark questions.
That is why this hire matters.
Procode's strategy is becoming one of the clearest tests of the AI-enabled RCM roll-up model.
The thesis is straightforward:
Acquire high-quality specialty billing businesses.
Keep the domain expertise and customer relationships.
Standardize the operating model.
Embed proprietary AI into coding and collections.
Use the resulting productivity gains to improve both provider outcomes and the economics of the acquired company.
That sounds obvious in a pitch deck.
It is much harder in practice.
Hiring an operator from Optum whose explicit mandate is to turn acquired billing companies into one AI-enabled platform suggests Procode knows the next phase will be won through integration and execution — not another model demo.
For the broader RCM market, that may be the bigger signal.
The next generation of consolidators may not simply buy revenue-cycle companies. They may buy them as distribution and workflow infrastructure, then use AI to change the economics after the deal closes.
Related RCAI analysis: Procode's $10M Series A and surgical coding AI benchmark →
Daily coverage of payer policy, denials, deals, and vendor moves — written for people who live in revenue cycle.
Source: Procode via PR Newswire · RevCycleAI analysis · October 6, 2026